MLYS · Mineralys Therapeutics, Inc.
$25.13
+0.65 (+2.66%)
At close · Sep 30
Return incl. dividend (before tax)
Market Cap
$2.29B
Shares
88.41M
Volume · Sep 30
2.05M
Avg daily vol (3M)
1.03M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$25.13
Open$24.48
Day$24.44–25.89
52W close$22.50–47.33
Avg vol 30d1.3M
Short int9.2M · 10.4% float · 6.4d
Short vol54%
Last earningsAug 11, 2026
DataFeb 2023–Sep 2026
Filing10-Q · Aug 11
Up next
Next earnings call
Nov 13, 2026
Est · unconfirmed
· in 6 wks
filed Aug 11, 2026
call held Aug 11, 2026
Metrics snapshot
Useful current figures from the complete screener profile.
Revenue (TTM)
—
Trailing 12 months
Net income (TTM)
—
Trailing 12 months
Revenue growth YoY
—
Year over year
Operating margin
—
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
—
Year over year · more shares
Price change (1Y)
-37.8%
Trailing year
Short interest
10.4%
Latest settlement · 6.4 days to cover
Equibles Rating
blended score · not investment adviceOverall
Strong Sell
SellHoldBuy
Technical
Strong Sell
Momentum
Very Weak
Sentiment
Bullish
Fundamentals
Limited
Quant / Vol
Very High
Market backdrop
VIX 16.3 · calm
Equity put/call 0.53
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−12%
below
Price vs 50-day avg
−7%
below
RSI (14)
40
neutral
MACD trend
Negative
52-week position
11%
near low
Momentum
relative strength
1-month return
−2%
trailing
6-month return
−8%
trailing
YTD return
−31%
this year
Relative strength
−20%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $27 › 200d $29 — 200d above 50d
Institutional flow
Accumulating
+4% holders QoQ · +34 funds added
Insider flow
Distributing
Net -$3.0M over 90 days · 100% sells
Short interest
Falling
10.39% of float · ▼ -1.6% MoM · 6.4 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
227 holders — near 3-yr high, broad support
Squeeze score
65
elevated · 0–100
Fundamentals
Not enough data for a confident read.
Quant / Vol
risk profile
Volatility
60%
annualized · 1-yr
Max drawdown
−52%
past year
ATR
5.9%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Strong Sell
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−12%
Bearish
Price vs 50-day avg
−7%
Bearish
RSI (14)
40
Neutral
MACD trend
Negative
Bearish
52-week position
11%
Bearish
Market signals — smart money & positioning
Bullish · 3 of 6
Trend (MA cross)
No cross
50d $27 › 200d $29 — 200d above 50d
Institutional flow
Accumulating
+4% holders QoQ · +34 funds added
Insider flow
Distributing
Net -$3.0M over 90 days · 100% sells
Short interest
Falling
10.39% of float · ▼ -1.6% MoM · 6.4 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
227 holders — near 3-yr high, broad support
Price context
position in its 52-week range
Range low $23
Now $25 · 11%
Range high $47
vs 200-day avg -12%
vs 50-day avg -7%
Illustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
Earlier KPI extraction records exist, but do not meet the current evidence-completeness requirements. No current verified series is available. Earlier figures remain withheld until revalidated; this is not evidence that the company reports no KPIs.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
MLYS
this stock
Mineralys Therapeutics, Inc.
|
$2.29B | -30.8% | — | — | 10.4% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$133.37B | +15.3% | +46.2% | 30.7 | 1.9% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$81.13B | -1.8% | +20.8% | 19.5 | 2.5% |
|
MRNA
Moderna, Inc.
|
$79.40B | +553.0% | +4.3% | — | 8.2% |
|
CSLLY
Csl Ltd
|
$61.25B | — | — | — | 0.0% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Smart Money
Financials
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| MLYS | -6.6% | -1.7% | -7.5% | -2.1% | -30.8% |
| SPY | -0.7% | +0.1% | +12.2% | -0.6% | +11.8% |
| vs SPY | -5.9% | -1.8% | -19.7% | -1.5% | -42.6% |